AIM ImmunoTech Inc. (AIM) earnings
Quarterly results of AIM ImmunoTech Inc. as filed with the SEC: revenue, net income and earnings per share for each of the last 8 quarters, the latest results release and when the next one is expected.
Latest quarter: Q2 FY2026
In Q2 FY2026 (ended June 30, 2026) AIM ImmunoTech Inc. reported revenue of $26K (+4% on the same quarter a year earlier) and a net loss of $3.8M.
Diluted earnings per share were -$0.43.
Quarter by quarter
| Quarter | Revenue | vs year ago | Net income | EPS |
|---|---|---|---|---|
| Q2 FY2026 | $26K | +4% | -$3.8M | -$0.43 |
| Q1 FY2026 | $22K | +37.5% | -$3M | -$0.69 |
| Q4 FY2025 | $21K | -53.3% | -$4.2M | - |
| Q3 FY2025 | $26K | -25.7% | -$3.3M | $1.57 |
| Q2 FY2025 | $25K | - | -$2.8M | -$3.68 |
| Q1 FY2025 | $16K | - | -$3.7M | -$0.05 |
| Q4 FY2024 | $45K | - | -$6M | - |
| Q3 FY2024 | $35K | - | -$3.7M | -$6.00 |
Results filings
- Quarterly results 8-K
- Quarterly report 10-Q
What were AIM ImmunoTech Inc.'s latest quarterly results?
For Q2 FY2026, which ended June 30, 2026, AIM ImmunoTech Inc. reported revenue of $26K and a net loss of $3.8M. The figures come from its filing with the SEC.
Is AIM ImmunoTech Inc.'s revenue growing?
Revenue in Q2 FY2026 was $26K, up 4% from $25K in the same quarter a year earlier.
Get an email when AIM reports
Follow AIM and we email you its next results the day they are filed, with the numbers explained.